Age-related longitudinal changes in metabolic energy expenditure during walking in boys with duchenne muscular dystrophy

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Brehm, Merel Anne ^a,b   Kempen, Jiska C E ^a   Van Der Kooi, Anneke J ^b   De Groot, Imelda J M ^c   Van Den Bergen, Janneke C ^d   Verschuuren, Jan J G M ^d   Niks, Erik H ^d   Harlaar, Jaap ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEFLAZACORT; PREDNISONE;

6 MINUTE WALK TEST; AGE; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ENERGY CONSUMPTION; ENERGY COST; ENERGY EXPENDITURE; ENERGY METABOLISM; EXERCISE TEST; FOLLOW UP; GENDER; HUMAN; MALE; MOBILIZATION; MOTOR PERFORMANCE; PRESCHOOL CHILD; SCHOOL CHILD; WALKING; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGE FACTORS; CHILD; ENERGY METABOLISM; EXERCISE TEST; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; WALKING;

EID: 84918774996     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115200     Document Type: Article

References (31)

1. Mendell JR, Shilling C, Leslie ND, Flanigan KM, al-Dahhak R, et al. (2012) Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol 71: 304-313.
2. Lapidos KA, Kakkar R, McNally EM (2004) The dystrophin glycoprotein complex: signalling strength and integrity for the sarcolemma. Circ Res 94: 1023-1031.
3. Bushby K, Finkel R, Birnkrant D, Case LE, Clemens PR, et al. (2010) Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurology 9(2): 177-189.
4. McDonald CM, Henricson EK, Han JJ, Abresch RT, Nicorici A, et al. (2010) The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve 41(4): 500-510.
5. Kempen JC, Harlaar J, van der Kooi AJ, de Groot IJ, van den Bergen JC, et al. (2014) Reliability of the walking energy cost test and the six-minute walk test in boys with Duchenne muscular dystrophy. Neuromuscul Disord 24(3): 216-221.
6. Bar-Or O (1996) Role of exercise in the assessment and management of neuromuscular disease in children. Med Sci Sports Exerc 28(4): 421-427.
7. Bendixen RM, Senesac C, Lott DJ, Vandenborne K (2012) Participation and quality of life in children with Duchenne muscular dystrophy using the International Classification of Functioning, Disability, and Health. Health Qual Life Outcome 10(43): 1-9.
8. Waters RL, Hislop HJ, Thomas L, Campbell J (1983) Energy cost of walking in normal children and teenagers. Dev Med Child Neurol 25(2): 184-188.
9. Van de Walle P, Desloovere K, Truijen S, Gosselink R, Aerts P, et al. (2010) Age-related changes in mechanical and metabolic energy during typical gait. Gait Posture 31(4): 495-501.
10. McDonald CM, Henricson EK, Han JJ, Abresch RT, Nicorici A, et al. (2010) The 6-minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observations. Muscle Nerve 42: 966-974.
11. Mazzone E, Vasco G, Sormani MP, Torrente Y, Berardinelli A, et al. (2011) Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. Neurology 77(3): 250-256.
12. Henricson E, Abresch R, Han JJ, Nicorici A, Goude Keller E, et al. (2013) The 6-Minute Walk Test and Person-Reported Outcomes in Boys with Duchenne Muscular Dystrophy and Typically Developing Controls: Longitudinal Comparisons and Clinically-Meaningful Changes Over One Year. PLoS Curr 8(5): 1-20.
13. Goemans N, van den Hauwe M, Wilson R, van Impe A, Klingels K, et al. (2013) Ambulatory capacity and disease progression as measured by the 6-minute-walk-distance in Duchenne muscular dystrophy subjects on daily corticosteroids. Neuromuscul Disord 23(8): 618-623.
14. Mazzone ES, Pane M, Sormani MP, Scalise R, Berardinelli A, et al. (2013) 24 month longitudinal data in ambulant boys with duchenne muscular dystrophy. PLoS One 8(1): e52512.
15. Brehm MA, Harlaar J, Groepenhof H (2004) Validation of the portable VmaxST system for oxygen-uptake measurement. Gait Posture 20(1): 67-73.
16. American Thoracic Society (2002). ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1): 111-117.
17. Garby L, Astrup A (1987) The relationship between the respiratory quotient and the energy equivalent of oxygen during simultaneous glucose and lipid oxidation and lipogenesis. Acta Physiol Scand 129(3): 443-444.
18. Schwartz MH, Koop SE, Bourke JL, Baker R (2006) A nondimensional normalization scheme for oxygen utilization data. Gait Posture 24: 14-22.
19. Waters RL, Mulroy S (1999) The energy expenditure of normal and pathologic gait. Gait Posture 9(3): 207-231.
20. Marconi V, Carraro E, Trevisi E, Capelli C, Martinuzzi A, et al. (2012) The Locomotory Index in diplegic and hemiplegic children: the effects of age and speed on the energy cost of walking. Eur J Phys Rehabil Med 48(3): 403-412.
21. Brehm MA, Nollet F, Harlaar J (2006) Energy demands of walking in persons with postpoliomyelitis syndrome: relationship with muscle strength and reproducibility. Arch Phys Med Rehabil 87(1): 136-140.
22. Morgan DW, Tseh W, Caputo JL, Keefer DJ, Craig IS, et al. (2004) Longitudinal stratification of gait economy in young boys and girls: the locomotion energy and growth study. Eur J Appl Physiol 91: 30-34.
23. Thomas SS, Buckon CE, Russman BS, Sussman MD, Aiona MD (2011) A comparison of the changes in the energy cost of walking between children with cerebral palsy and able-bodied peers over one year. J Pediatr Rehabil Med 4(3): 225-233.
24. Priede IG (1977) Natural selection for energetic efficiency and the relationship between activity level and mortality. Nature 267: 610-611.
25. Waters RL, Lunsford BR, Perry J, Byrd R (1988) Energy speed relationship of walking - standard tables. J Orthop Res 6: 215-222.
26. Sutherland DH, Olshen R, Cooper L, Wyatt M, Leach J, et al. (1981) The pathomechanics of gait in Duchenne muscular dystrophy. Dev Med Child Neurol 23: 3-22.
27. Hsu J, Furumasu J (1993) Gait and posture changes in the Duchenne muscular dystrophy child. Clin Orthop Relat Res 288: 122-125.
28. D'Angelo MG1, Berti M, Piccinini L, Romei M, Guglieri M, et al. (2009) Gait pattern in Duchenne muscular dystrophy. Gait Posture 29: 36-41.
29. Sienko Thomas S, Buckon CE, Nicorici A, Bagley A, McDonald CM, et al. (2010) Classification of the gait patterns of boys with Duchenne muscular dystrophy and their relationship to function. J Child Neurol 25(9): 1103-1109.
30. European Medicines Agency (2013) Guideline on the clinical investigation of medicinal products for the treatment of Duchenne and Becker muscular dystrophy (draft). London: European Medicines Agency.
31. McDonald CM, Henricson EK, Abresch RT, Florence JM, Eagle M, et al. (2013) The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study. Muscle Nerve 48(3): 343-356.